Pyridostigmine Bromide Tablet
Product Images NDC 58657-810

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 58657-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Method Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Desc (Desc)

Chemical structure of pyridostigmine bromide showing a pyridine ring bonded to a carbamate group and associated bromide ion.*

FDA Label Image

Bottle-lab (Bottle Label)

Pyridostigmine Bromide Tablets, USP 30 mg oral tablets in a unit-of-use package containing 21 tablets. The label shows the product is Rx only and is distributed by Method Pharmaceuticals, LLC. Instructions note the tablets contain 30 mg of Pyridostigmine Bromide and caution that the tablets are moisture sensitive, advising not to remove the desiccant and to keep the container tightly closed.*

FDA Label Image

Carton (Carton)

Packaging label for Pyridostigmine Bromide Tablets, USP 30 mg by Method Pharmaceuticals, LLC. The label indicates 210 tablets per carton (21 cards of 10 tablets each). Instructions include storage at 25°C with allowed excursions and a notice for prescription use only. The label cautions against moisture and emphasizes child safety and proper use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.